Markets:

Overview

News

Currencies

International

Treasuries

Poseida Therapeutics, Inc. - Common Stock (NQ:PSTX)

9.500 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Poseida Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views ↗

November 26, 2024

Via Benzinga

Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results ↗

November 26, 2024

Via Benzinga

US Stocks Mixed; Best Buy Posts Downbeat Earnings ↗

November 26, 2024

Via Benzinga

Where Poseida Therapeutics Stands With Analysts ↗

November 15, 2024

Via Benzinga

Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details ↗

November 26, 2024

Roche agrees to acquire Poseida Therapeutics for $1.5 billion, expanding its CAR-T therapy platform with a focus on hematologic malignancies and solid tumors.

Via Benzinga

Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket ↗

November 26, 2024

Via Benzinga

Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday ↗

November 26, 2024

Via Benzinga

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 05, 2024

PSTX stock results show that Poseida Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 11, 2024

Via Benzinga

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

PSTX stock results show that Poseida Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 16, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 16, 2024

Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 15, 2024

Via Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 11, 2024

Via Benzinga

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday ↗

March 11, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Via Benzinga

Topics Stocks

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q4 2023 ↗

March 07, 2024

PSTX stock results show that Poseida Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial ↗

December 11, 2023

Poseida Therapeutics Inc (NASDAQ: PSTX) released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 11, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 11, 2023

It's time to start the trading week with a look at the biggest pre-market stock movers worth watching for Monday morning!

Via InvestorPlace

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare ↗

November 17, 2023

Are you looking for biotech breakthrough stocks? Here are three revolutionary stocks redefining healthcare.

Via InvestorPlace

Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich ↗

October 03, 2023

Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 07, 2023

Via Benzinga

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗

August 09, 2023

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

Via Benzinga

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Why Are Poseida Therapeutics Shares Moving Higher Today? ↗

August 07, 2023

Poseida Therapeutics Inc (NASDAQ: PSTX) shares are trading higher after the company received a $50 million strategic investment by Astellas Pharma Inc (OTC: ALMPY) (OTC:

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.